Perspectives of pharmacotherapy in Alzheimer's disease

Japanese Journal of Pharmacology

Volumn 80, Issue 1, 1999, Pages 9-14

  Yamada, Kiyofumi ^a   Ren, Xiuhai ^a   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Animal model; Learning and memory; amyloid

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DONEPEZIL; ESTROGEN; IDEBENONE; INDOMETACIN; NEFIRACETAM; NONSTEROID ANTIINFLAMMATORY AGENT; NOOTROPIC AGENT; PROPENTOFYLLINE; RIVASTIGMINE; TACRINE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOUSE; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 0032972171     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.80.9     Document Type: Review

References (30)

1. Yankner BA: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932 (1996)
2. Hardy H: Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20, 154-159 (1997)
3. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N and Ihara Y: Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53 (1994)
4. Busciglio J, Lorenzo A, Yeh J and Yankner BA: β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888 (1995)
5. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B and Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717Fβ-amyloid precursor protein. Nature 373, 523-527 (1995)
6. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D and Hyman BT: Aβ desposition is associated with neuropil changes, but not with overt neuronal loss in the human precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17, 7053-7059 (1997)
7. Higgins LS, Holzman DM, Rabin J, Mobley WC and Cordell B: Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol 35, 598-607 (1994)
8. Moran PM, Higgins LS, Cordell B and Moser PC: Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc Natl Acad Sci USA 92, 5341-5345 (1995)
9. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F and Cole G: Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996)
10. Pappolla MA, Chyan Y-J, Hsiao K, Perry G, Smith MA and Bozner P: Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease. A chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152, 871-877 (1998)
11. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun M, Jucker M, Probst A, Staufenbiel M and Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94, 13287-13292 (1997)
12. Nitta A, Itoh A, Hasegawa T and Nabeshima T: β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170, 63-66 (1994)
13. Nitta A, Fukuta T, Hasegawa T and Nabeshima T: Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 73, 51-57 (1997)
14. Maurice T, Lockhart BP and Privat A: Amnesia induced by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res 706, 181-193 (1996)
15. 24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav Brain Res 90, 133-145 (1998)
16. Netland EE, Newton JL, Majocha RE and Tate BA: Indomethacin reverses the microglial response to amyloid β-protein. Neurobiol Aging 19, 201-204 (1998)
17. Morimoto K, Yoshimi K, Tonohiro T, Yamada N and Kaneko I: Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. Neuroscience 84, 479-487 (1998)
18. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T and Nabeshima T: Protective effects of idebenone and α-tocopherol on β-amyloid-(1-42) induced learning and memory deficits in rats: implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11, 83-90 (1999)
19. Yamada K, Tanaka T, Mamiya T, Shiotani T, Kameyama T and Nabeshima T: Improvement by nefiracetam of β-amyloid-(1-42)-induced learning and memory impairments in rats. Br J Pharmacol 126, 235-244 (1999)
20. Auld DS, Kar S and Quirion R: β-Amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends Neurosci 21, 43-49 (1998)
21. Itoh A, Nitta A, Nadai M, Nishimura K, Hirose M, Hasegawa T and Nabeshima T: Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J Neurochem 66, 1113-1117 (1996)
22. Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, Saitoh Y, Ishiguro K, Hoshino T and Imahori K: Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain. Proc Natl Acad Sci USA 93, 2719-2723 (1996)
23. Nabeshima T and Itoh A: Toxicity of β-amyloid protein: neurochemical, histological and behavioral changes. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Edited by Iqbal K, Winblad B, Nishimura T, Takeda M and Wisniewski HM, pp 623-630, John Wiley & Sons Ltd, Chichester, England (1997)
24. Cullen WK, Suh YH, Anwyl R and Rown MJ: Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragment. Neuroreport 8, 3213-3217 (1997)
25. Wu J, Anwyl R and Rowan MJ: β-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur J Pharmacol 284, R1-R3 (1995)
26. 25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 83, 413-428 (1998)
27. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C and Brandt J: Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45, 51-55 (1995)
28. Simpkins JW, Green P, Gridley KE, Singh M, de Fiebre NC and Rajakumar G: Role of estrogen replacement therapy in memory enhancement and prevention of neuronal loss associated with Alzheimer's disease. Am J Med 103 (3A), 19S-25S (1997)
29. Yamada K, Tanaka T, Senzaki K, Kameyama T and Nabeshima T: Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40). Eur J Pharmacol 349, 15-22 (1998)
30. Tanaka T, Yamada K, Senzaki K, Narimatsu H, Nishimura K, Kameyama T and Nabeshima T: NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by β-amyloid protein in rats. Eur J Pharmacol 352, 135-142 (1998)